Soni Manmeet Singh
Company insiders · COO and CFO · Director · Summit Therapeutics Inc.
- Reported transaction lines
- 2
- Buy lines
- 0
- Sell lines
- 0
Filing activity by month
Original filing lines in up to 12 months with activity.
- 2026-112
Frequently disclosed stocks
Disclosure history
| Reporting investor | Security | Activity | Transaction / period | Filed | Reported amount | Source |
|---|---|---|---|---|---|---|
| Soni Manmeet Singh COO and CFO · Director · Summit Therapeutics Inc. | SMMT Summit Therapeutics Inc. | Exercise or conversionFiling detailsSEC transaction code M Stock Option (right to buy) · Derivative security · Direct ownership · Reported balance after transaction: 100000 · On November 16, 2026, the Reporting Person exercised an option to purchase 100,000 shares of the Issuer's common stock at an exercise price of $1.37 per share. · The option was granted on December 23, 2019. The shares underlying the option vested in four equal annual installments, with the first such installment beginning on December 23, 2020. | 2026-11-16 | 2026-11-16 | 100,000 shares/units | SEC 4 |
| Soni Manmeet Singh COO and CFO · Director · Summit Therapeutics Inc. | SMMT Summit Therapeutics Inc. | Exercise or conversionFiling detailsSEC transaction code M Common Stock · Direct ownership · Reported balance after transaction: 3224375 · On November 16, 2026, the Reporting Person exercised an option to purchase 100,000 shares of the Issuer's common stock at an exercise price of $1.37 per share. · Holdings include shares previously acquired through exempt transactions pursuant to the Issuer's employee stock purchase plan. | 2026-11-16 | 2026-11-16 | 100,000 shares/units | SEC 4 |
Counts describe original filing lines in BriefStock’s coverage. Later amendments can correct or supplement them. Check the original filing for ownership and transaction details.